Ranitidine

Manufacturer
CARDINAL HEALTH
Effective date
2019-06-11
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
legacy-cache
Hydrated at
2026-08-01 21:40:39

Label at a glance#

ProductRanitidine
Active ingredientranitidine hydrochloride
Label structure11 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) do not chew tablet children under 12 years: ask a doctor

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 75 mg (as ranitidine hydrochloride USP, 84 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor.
  • with other acid reducers

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
    • do not chew tablet
  • children under 12 years: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • do not use if carton or printed foil under cap is open or torn
  • avoid excessive heat or humidity
  • store at 20°-25°C (68°-77°F)
  • this product is sodium and sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.

Questions?

OTC - QUESTIONS SECTION

Call 1-888-375-3784

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

Bottle label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BottleBottle

Carton label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CartonCarton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70000-0033-12025-04-29C16284748780-12cef2736-9ea9-d83d-e063-dadaa90ab31fDrug Facts
70000-0033-22025-04-29C16284748780-12cef2736-9ea9-d83d-e063-dadaa90ab31fDrug Facts
70000-0033-12025-01-30C16284748780-12cef2736-9ea9-d83d-e063-dadaa90ab31fDrug Facts
70000-0033-22025-01-30C16284748780-12cef2736-9ea9-d83d-e063-dadaa90ab31fDrug Facts

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70000-003370000-0033-1, 70000-0033-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A075294-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2884e616aacf4f…
2026-08-18 06:07:402026-07A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-283f01610625f2…
2019-09-15 20:21 UTC2019-09A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A075294-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2000-03-28f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1bfd603a-c252-5b5c-9b8d-5804e9914615a3fca08d-6e8a-9f59-f452-2a0a94c659d92019-09-30WarningsExact identifier
spl set id: a3fca08d-6e8a-9f59-f452-2a0a94c659d9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.